Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Medical Genetics

The Biology and Diagnosis of MTHFR Deficiency

At a Glance

Severe MTHFR deficiency typically causes extremely high homocysteine with low or normal methionine, so routine newborn screening may miss it. Diagnosis combines targeted blood testing with MTHFR genetic analysis and, in selected cases, enzyme testing.

To understand severe MTHFR deficiency, it helps to picture your body’s cellular pathways. The MTHFR enzyme is responsible for converting one form of folate into another called 5-MTHF [1].

This 5-MTHF is a crucial element that the body uses to turn a potentially harmful substance, homocysteine, into a necessary building block called methionine [2][3]. When the MTHFR enzyme is severely impaired due to rare genetic mutations, homocysteine builds up in the blood, and the body runs low on methionine, which is essential for numerous cellular functions [4][5].

The Biochemical Signature

Doctors look for a specific laboratory pattern to diagnose this condition. This signature helps differentiate severe MTHFR deficiency from other metabolic disorders [4][6].

Marker Typical MTHFR Deficiency Pattern Clinical Importance
Total Homocysteine (tHcy) Extremely High Markedly elevated levels are a hallmark of untreated severe disease and pose risks to the brain and vasculature [7][8].
Methionine Low or Normal Low levels indicate the remethylation process is impaired [4].
Methylmalonic Acid (MMA) Normal MMA is assessed to help identify other disorders. Note: A normal MMA does NOT completely rule out all B12 (cobalamin) defects.

Note: There is no single “toxicity threshold” for homocysteine. Risk depends on the individual, clinical context, and treatment status.

Differentiating from CBS Deficiency (and Diet Implications)

There is another well-known cause of high homocysteine called CBS deficiency (classic homocystinuria). In CBS deficiency, both homocysteine and methionine are usually high [6][9]. Because their methionine is high, patients with CBS deficiency often must eat a strictly low-protein/low-methionine diet.

Patients with MTHFR deficiency should NOT blindly adopt a low-protein CBS diet. Because MTHFR patients often have low or normal methionine, restricting protein further can be dangerous. Dietary management must be explicitly guided by a metabolic dietitian [4].

Why Newborn Screening Might Miss It

Many parents are shocked to learn that a child can have a severe metabolic disorder even if their routine newborn screening (the “heel prick”) came back normal. Most traditional screening programs are designed to find CBS deficiency by looking for high methionine [6].

Because babies with MTHFR deficiency usually have low or normal methionine, they do not trigger the standard alarms [10]. While some advanced screening programs now use total homocysteine as a “second-tier” test, it is not yet universal [11][12]. If an infant develops symptoms or has an affected sibling, targeted homocysteine testing is required regardless of a normal routine newborn screen [13].

Confirming the Diagnosis

The diagnosis generally relies on integrating the biochemical pattern with specialized testing:

  1. Molecular Genetic Analysis: This looks for pathogenic variants in both copies of the MTHFR gene. This is fundamentally different from having a “common polymorphism” like C677T or A1298C, which are minor variations [14][7].
  2. Fibroblast Enzyme Testing: In some selected, complex cases, doctors may take a skin biopsy to measure the exact MTHFR enzyme activity in lab-grown cells. While severe cases typically show very low residual activity, this test is specialized, not universally required, and a specific percentage does not perfectly predict an individual’s future disease course [14][15][16].

Furthermore, because some rare intracellular cobalamin defects (like cblE or cblG) can present with high homocysteine and normal MMA, the clinical picture, genetics, and folate/B12 status must all be interpreted together by an expert [6].

Common questions in this guide

What blood test pattern suggests severe MTHFR deficiency?
Severe MTHFR deficiency usually causes extremely high total homocysteine, with methionine that is low or normal. Methylmalonic acid is typically normal, although a normal result does not rule out every vitamin B12-related disorder. There is no single homocysteine value that defines toxicity for every person.
Can routine newborn screening miss MTHFR deficiency?
Yes. Many standard newborn screening programs look for high methionine, which is more typical of CBS deficiency, while babies with MTHFR deficiency often have low or normal methionine. Targeted homocysteine testing may be needed when an infant has symptoms or an affected sibling, even after a normal routine screen.
How is MTHFR deficiency confirmed?
Diagnosis combines the blood pattern with molecular genetic testing that looks for disease-causing variants in both copies of the MTHFR gene. In selected complex cases, a skin biopsy may be used to measure MTHFR enzyme activity in cultured cells. Doctors also consider folate status, vitamin B12 status, and other causes of high homocysteine.
Is severe MTHFR deficiency the same as common C677T or A1298C variants?
No. Severe MTHFR deficiency is caused by rare disease-causing genetic changes that substantially impair enzyme function, while C677T and A1298C are common genetic variations and are not the same diagnosis. A common variant panel cannot by itself confirm severe MTHFR deficiency.
Why should someone with MTHFR deficiency avoid an automatic low-protein diet?
People with MTHFR deficiency often have low or normal methionine, so restricting protein or methionine without medical guidance may make the nutritional imbalance worse. Dietary changes should be individualized and supervised by a metabolic dietitian rather than copied from a CBS deficiency diet.
Can vitamin B12 disorders also cause high homocysteine with normal methylmalonic acid?
Yes. Some intracellular vitamin B12 disorders, including cblE and cblG defects, can produce high homocysteine with normal methylmalonic acid. The clinical history, genetic testing, and folate and B12 evaluation must be interpreted together by a metabolic specialist.

Get notified when new evidence is published on Homocystinuria due to methylene tetrahydrofolate reductase deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (16)
  1. 1

    Functional characterization of missense mutations in severe methylenetetrahydrofolate reductase deficiency using a human expression system.

    Burda P, Suormala T, Heuberger D, et al.

    Journal of inherited metabolic disease 2017; (40(2)):297-306 doi:10.1007/s10545-016-9987-0.

    PMID: 27743313
  2. 2

    Treatment with Mefolinate (5-Methyltetrahydrofolate), but Not Folic Acid or Folinic Acid, Leads to Measurable 5-Methyltetrahydrofolate in Cerebrospinal Fluid in Methylenetetrahydrofolate Reductase Deficiency.

    Knowles L, Morris AA, Walter JH

    JIMD reports 2016; (29()):103-107 doi:10.1007/8904_2016_529.

    PMID: 26898294
  3. 3

    Structural basis for the regulation of human 5,10-methylenetetrahydrofolate reductase by phosphorylation and S-adenosylmethionine inhibition.

    Froese DS, Kopec J, Rembeza E, et al.

    Nature communications 2018; (9(1)):2261 doi:10.1038/s41467-018-04735-2.

    PMID: 29891918
  4. 4

    Methylene Tetrahydrofolate Reductase Deficiency.

    Kaur R, Correa ARE, Thakur S, et al.

    Indian journal of pediatrics 2020; (87(11)):951-953 doi:10.1007/s12098-020-03290-3.

    PMID: 32451826
  5. 5

    RNA sequencing combined with whole-exome sequencing revealed familial homocystinemia due to MTHFR deficiency and its complex splicing events.

    Li W, Ma X, Sun Y, et al.

    Gene 2025; (936()):149101 doi:10.1016/j.gene.2024.149101.

    PMID: 39571660
  6. 6

    First Revision of the Guidelines for the Diagnosis and Management of Remethylation Disorders.

    Olivieri G, Bordugo A, Burnyte B, et al.

    Journal of inherited metabolic disease 2026; (49(4)):e70177 doi:10.1002/jimd.70177.

    PMID: 42231716
  7. 7

    Manifestations of neurological symptoms and thromboembolism in adults with MTHFR-deficiency.

    Rommer PS, Zschocke J, Fowler B, et al.

    Journal of the neurological sciences 2017; (383()):123-127 doi:10.1016/j.jns.2017.10.035.

    PMID: 29246599
  8. 8

    Severe 5,10-methylenetetrahydrofolate reductase deficiency: a rare, treatable cause of complicated hereditary spastic paraplegia.

    Perna A, Masciullo M, Modoni A, et al.

    European journal of neurology 2018; (25(3)):602-605 doi:10.1111/ene.13557.

    PMID: 29284203
  9. 9

    Homocysteinemia due to MTHFR deficiency in a young adult presenting with bilateral lens subluxations.

    Couser NL, McClure J, Evans MW, et al.

    Ophthalmic genetics 2017; (38(1)):91-94 doi:10.3109/13816810.2016.1143017.

    PMID: 27046515
  10. 10

    Pilot Study on Neonatal Screening for Methylmalonic Acidemia Caused by Defects in the Adenosylcobalamin Synthesis Pathway and Homocystinuria Caused by Defects in Homocysteine Remethylation.

    Kagawa R, Tajima G, Maeda T, et al.

    International journal of neonatal screening 2021; (7(3)) doi:10.3390/ijns7030039.

    PMID: 34287232
  11. 11

    Newborn screening for homocystinurias: Recent recommendations versus current practice.

    Keller R, Chrastina P, Pavlíková M, et al.

    Journal of inherited metabolic disease 2019; (42(1)):128-139 doi:10.1002/jimd.12034.

    PMID: 30740731
  12. 12

    Newborn screening for homocystinurias and methylation disorders: systematic review and proposed guidelines.

    Huemer M, Kožich V, Rinaldo P, et al.

    Journal of inherited metabolic disease 2015; (38(6)):1007-19 doi:10.1007/s10545-015-9830-z.

    PMID: 25762406
  13. 13

    Hypoventilation and progressive encephalopathy in a neonate with MTHFR deficiency.

    Vemireddy K, Panigrahy N, Lingappa L, Chirla D

    BMJ case reports 2022; (15(1)) doi:10.1136/bcr-2021-246431.

    PMID: 34983810
  14. 14

    Development of a novel liquid chromatography-tandem mass spectrometry based enzymatic assay of 5,10-methylenetetrahydrofolate reductase.

    Sunoki K, Watanabe M, Aoki S, et al.

    Scientific reports 2025; (15(1)):22674.

    PMID: 40596302
  15. 15

    Insights into severe 5,10-methylenetetrahydrofolate reductase deficiency: molecular genetic and enzymatic characterization of 76 patients.

    Burda P, Schäfer A, Suormala T, et al.

    Human mutation 2015; (36(6)):611-21 doi:10.1002/humu.22779.

    PMID: 25736335
  16. 16

    Clinical pattern, mutations and in vitro residual activity in 33 patients with severe 5, 10 methylenetetrahydrofolate reductase (MTHFR) deficiency.

    Huemer M, Mulder-Bleile R, Burda P, et al.

    Journal of inherited metabolic disease 2016; (39(1)):115-24 doi:10.1007/s10545-015-9860-6.

    PMID: 26025547

This page explains the biology and diagnostic testing for MTHFR deficiency for informational purposes only and does not constitute medical advice. A metabolic specialist and genetic counselor should interpret your homocysteine, methionine, genetic, and enzyme results.